Patient
SITE003-0293
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE003 (CAN) (Dr. Okafor)
consented 2026-08-23
Adverse events
0
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 0
No adverse events recorded
Events reported by the site or through Luna appear here.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.